Oxybutynin

Breastfeeding
  • TRADE NAMES: Cystrin (Sanofi-Aventis); Ditropan (Ortho-McNeil); Dridase; Gelnique; Lyrinel (Janssen-Cilag); Novitropan; Oxyban; Oxybutyn; Oxytrol; Tropax; Uromax
  • INDICATIONS: Neurogenic bladder, urinary incontinence, palmar and axillary hyperhidrosis
  • CLASS: Anticholinergic, Muscarinic antagonist
  • HALF-LIFE: 2–3 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Anticholinergics, Antihistamines, Arbutamine, Cannabinoids, Clozapine, Conivaptan, Diphenoxylate, Disopyramide, Domperidone, Haloperidol, Ketoconazole, Levodopa, MAO inhibitors, Memantine, Metoclopramide, Nefopam, Nitrates, Parasympathomimetics, Pramlintide, Secretin, Tricyclic antidepressants

PREGNANCY CATEGORY: B

Contra-indicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions.

Our database has 43 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 07/31/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top